Table 1 Prevalence of women who had Covid-19 in pregnancy in the studied cohort (n = 315) according to type of testing
From: Clinical relevance of SARS-CoV-2 infection in late pregnancy
Diagnostic test | N | Rate | 95%CI |
|---|---|---|---|
Naso-pharyngeal swab RT-PCR | 13 | 4.1% | 2.4–6.9% |
Antibodies againts CoV-2 envelope | 20 | 6.4% | 4.2–9.6% |
Antibodies againts CoV-2 nucleoprotein | 21 | 6.7% | 4.4–10.0% |
At least one | 28 | 8.9% | 6.2–12.5% |